Controversy over Corona vaccine in India. The Central government has set up a special committee to look into various aspects of the covid vaccine plan.
 |
| The expert committee will also decide which vaccines India will use, financially and on whose body the vaccine will be administered first |
The expert committee of the Central is going to meet today to discuss the collection of corona vaccine and its application in human body. The Central government has set up a special committee to look into various aspects of the Covid vaccine plan.
The committee has all the responsibilities, from identifying which vaccine to buy, to distributing the vaccine, to applying it to the human body. The committee will also decide which vaccines India will use, financially and on whose body the vaccine will be administered first.
According to the Union Ministry of Science and Technology, the Corona vaccine seems unlikely to arrive before 2021. On the other hand, ICMR claims that the first Covid vaccine will be launched in the country by August 15. Since then, there has been controversy among experts over the Covid vaccine.
According to some experts, covid vaccines are being marketed in a hurry. This can be a huge risk to public health. According to them, Covid vaccine niye needs more testing. According to the Ministry of Science, six Indian companies are already working on the corona vaccine. Two Indian vaccines, CO VACCINE and ZYCOV D, are in the testing phase. Of the 140 vaccines in the world, 11 have been tested on human bodies. It has been said that none of these are likely to hit the market before 2021.
According to health experts, it can take months or even years to run a tick test. Ranadeep Guleria, director of the All India Institute of Medical Sciences in Delhi, said it was not right to launch the Covid vaccine in such a hurry, as it could be unfavorable. Even the ticker seems to have enough potential for side effects.